CARBOPLATIN

By increasing the supply of meropenem, the number of cases can be greatly reduced. We at Venus strive to be the best meropenem injection manufacturer in India and be able to supply the injection not just nationally but also globally. For this purpose, we have also entered into distributio...

The company has been granted the license to market this drug in three different strengths: 50MG per 2ML 500MG per 5ML

Your Company has three manufacturing units that manufacture world-class products finding acceptance in advanced and developing pharmaceutical markets. Also, the Company has Globally-bench marked nine manufacturing facilities in Panchkula and Baddi (India) and a wholly-owned subsidiary in Germany, Venus Pharma GmbH,  that deals in Licensing, Packaging, Product Testing, Warehousing, and Logistics. The facilities are certified by ISO 9001, ISO 14001, OHSAS18001, European GMP, and other international regulatory authorities, which makes its products acceptable across the globe. Your Company is among the top leading global injectable manufacturers that cater to high-growth therapeutic segments.

For every pharmaceutical company, R&D is its backbone. Venus Medicine Research Centre (VMRC), the R&D arm of your Company, is a fully equipped interdisciplinary drug discovery and development centre located in Baddi, Himachal Pradesh. Accredited with GLP, VMRC is committed to bringing to the world novel breakthroughs that cater to critical care and super speciality segments.